Acute Phase Treatment for Infants Younger Than 1 Year of Age with Kawasaki Disease: A Single Center Retrospective Study
Journal Title: Journal of Advanced Research in Medicine - Year 2019, Vol 6, Issue 1
Abstract
Background: Infants younger than 1 year of age with Kawasaki disease (KD) have a high risk for coronary artery lesions (CAL). However, the appropriate acute phase treatment for the infants has not been established. Objective: To ascertain the usefulness of an initial single intravenous immunoglobulin (IVIG) therapy (2g/ kg) with delayed use of aspirin (DUA) for the infants. Materials and Methods: The outcomes in 205 patients who underwent initial single IVIG therapy at 2g/ kg/ dose with DUA for KD were investigated retrospectively. These subjects were divided into those aged <1 year (infant group, n = 43) and those aged 1 year or older (non-infant group, n=162). Statistical analyses were performed using Stat Flex Version 6 for Windows. Chi-square, Fisher’s exact, and Mann-Whitney U tests were used as appropriate, with sample size considerations. Results: Numbers of major signs in infant group were significantly fewer than those in non-infant group (median 5, interquartile range [IQ]: 5-5 vs. 6, IQ: 5-6, P <0.001). The prevalence of incomplete type (20.9% vs. 11.1%, P=0.091), timing of initial IVIG therapy in regards to day of illness onset (median 5, IQ: 5-6 vs. 5, IQ: 5-6, P=0.452), the prevalence of rescue therapies (9.3% vs. 13.6%, P=0.454), and CAL (0.0% vs. 3.1%, P=0.368) were similar between the 2 groups. No infants received steroids and had the CAL 3mm. The prevalence of initial IVIG therapy resistant patients in infant group was significantly lower than that in non-infant group (9.3% vs. 26.5%, P = 0.017). The defervescence days of illness in infant group were significantly earlier than those in non-infant group (median 6, IQ: 6-7 vs. 7, IQ: 6-8, P <0.001). Conclusion: The infants who are treated appropriately may not have a chance to higher risk of large CAL. An initial single IVIG therapy (2 g/kg) with DUA was useful for prevention of CAL 3 mm in infants with KD.
Authors and Affiliations
Toshimasa Nakada
Keywords
Related Articles
- EP ID EP669836
- DOI 10.24321/2349.7181.201901
- Views 104
- Downloads 0
Maternal and Fetal Outcome in Deranged Liver Function Test and Jaundice Complicating Pregnancy: A Prospective Study
Background: The objective of the study was to study maternal and fetal outcome in pregnancy complicated with deranged liver function test and jaundice. Methods: Total 150 antenatal patients with clinical or laboratory...
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome - Double Trouble
COPD- OSA overlap syndrome has been defined in the recent past as a syndrome of these two co-existing illnesses. Whether the overlap is synergistic is unknown, however it has been proven to have increased risk of complic...
New Oral Anticoagulants: An Overview
Oral anticoagulant therapy is used in the prevention and treatment of venous thromboembolism (VTE), prevention of stroke and other systemic emboli in patients with atrial fibrillation (AF) and artificial heart valves. V...
A Prospective Study to Evaluate the Prevalence of Infection in the Environment of ICU of a Tertiary Care Government Hospital
Introduction: The presence of microorganisms with acquired resistance to multiple antibiotics complicates the management and outcome of critically ill patients. In the intensive care units (ICUs), this can lead to increa...
A Study of Non-Scarring Diffuse Alopecia
Paucity of reports on non-scarring diffuse alopecia in women from this part of the world led us to take up this study. We examined 200 consecutive cases of non-scarring diffuse alopecia in women who attended the skin OPD...